KATHERINE DUNCAN: Open Payments
NPI 1083978753 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 52 payments from 14 companies in 2025. Trend: 2023 $1,856 · 2024 $1,123 · 2025 $1,566
Food & beverage: $1,566
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 5 | $212 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $207 |
| UCB, Inc. | 7 | $201 |
| Regeneron Healthcare Solutions, Inc. | 3 | $196 |
| E.R. Squibb & Sons, L.L.C. | 5 | $131 |
| ABBVIE INC. | 7 | $129 |
| Incyte Corporation | 2 | $111 |
| Organon LLC | 7 | $108 |
| GENZYME CORPORATION | 2 | $66 |
| Janssen Biotech, Inc. | 3 | $52 |
Products named: DUPIXENT, Bimzelx, ANZUPGO, Sotyktu, Leqselvi, SKYRIZI, OPZELURA, VTAMA.
Industry payments across AZ — which companies pay providers there.
